Skip to content
2000
Volume 3, Issue 1
  • ISSN: 2666-2906
  • E-ISSN: 2666-2914
Preview this article:

There is no abstract available.

Loading

Article metrics loading...

/content/journals/ijghd/10.2174/0126662906299185240520112218
2024-06-11
2025-01-19
Loading full text...

Full text loading...

References

  1. RavisankarP. A detailed analysis on acidity and ulcers in esophagus, gastric and duodenal ulcers and management.IOSR J. Dent. Med. Sci.201615194114
    [Google Scholar]
  2. TabibianJ.H. Digestive Problems Solved: A Patient’s Guide to Expert Insights and Solutions.Springer Nature202310.1007/978‑3‑031‑16317‑3
    [Google Scholar]
  3. AlhejailiR. AlomainyA. The use of wearable technology in providing assistive solutions for mental well-being.Sensors20232317737810.3390/s2317737837687834
    [Google Scholar]
  4. KhanA. KimA. SanossianC. FrancoisF. Impact of obesity treatment on gastroesophageal reflux disease.World J. Gastroenterol.20162241627163810.3748/wjg.v22.i4.162726819528
    [Google Scholar]
  5. ChapelleN. Ben GhezalaI. BarkunA. BardouM. The pharmacotherapeutic management of gastroesophageal reflux disease (GERD).Expert Opin. Pharmacother.202122221922710.1080/14656566.2020.181738532893683
    [Google Scholar]
  6. PerryI.E. SonuI. ScarpignatoC. AkiyamaJ. HongoM. VegaK.J. Potential proton pump inhibitor–related adverse effects.Ann. N. Y. Acad. Sci.202014811435810.1111/nyas.1442832761834
    [Google Scholar]
  7. TawamD. BaladiM. JungsuwadeeP. EarlG. HanJ. The positive association between proton pump inhibitors and clostridium difficile infection.Innov. Pharm.20211212110.24926/iip.v12i1.343934007671
    [Google Scholar]
  8. AlmuzainiR. AlmuzainiA.S. Mohammed AlqifariA. AlsohaibaniA. AlmutlaqL.Y. AlwehaibiR. AlfurayjiR.S. AlsamelT.A. Assessment of awareness and knowledge of proton pump inhibitors among the general population in the Qassim region, Saudi Arabia.Cureus20231510e4674910.7759/cureus.4674938021654
    [Google Scholar]
  9. DrossmanD.A. Functional gastrointestinal disorders: History, pathophysiology, clinical features, and Rome IV.Gastroenterology201615061262127910.1053/j.gastro.2016.02.032
    [Google Scholar]
  10. FloresL. KrauseC. PokalaB. HoseinS. ArmijoP.R. MishraT. KothariS. OleynikovD. Novel therapies for gastroesophageal reflux disease.Curr. Probl. Surg.2019561210069210.1016/j.cpsurg.2019.10069231837718
    [Google Scholar]
  11. BazerbachiF. KrishnanK. Abu DayyehB.K. Endoscopic GERD therapy: A primer for the transoral incisionless fundoplication procedure.Gastrointest. Endosc.201990337038310.1016/j.gie.2019.05.02831108091
    [Google Scholar]
  12. DunnC. BildzukewiczN. LiphamJ. Magnetic sphincter augmentation for gastroesophageal reflux disease.Gastrointest. Endosc. Clin. N. Am.202030232534210.1016/j.giec.2019.12.01032146949
    [Google Scholar]
  13. ZhuX. ShenJ. Anti-reflux mucosectomy (ARMS) for refractory gastroesophageal reflux disease.Eur. J. Med. Res.202429118510.1186/s40001‑024‑01789‑538500203
    [Google Scholar]
  14. Rodríguez de SantiagoE. Sanchez-VegazoC.T. PeñasB. ShimamuraY. TanabeM. Álvarez-DíazN. ParejoS. KazuyaS. Marcos-CarrascoN. Vazquez-SequeirosE. InoueH. AlbillosA. Antireflux mucosectomy (ARMS) and antireflux mucosal ablation (ARMA) for gastroesophageal reflux disease: A systematic review and meta-analysis.Endosc. Int. Open2021911E1740E175110.1055/a‑1552‑323934790538
    [Google Scholar]
  15. JirapinyoP. ThompsonC.C. Endoscopic gastric plication for the treatment of GERD and underlying class I obesity.VideoGIE202162747610.1016/j.vgie.2020.10.00333884332
    [Google Scholar]
  16. JirapinyoP. ThompsonC.C. Endoscopic gastric body plication for the treatment of obesity: Technical success and safety of a novel technique (with video).Gastrointest. Endosc.20209161388139410.1016/j.gie.2020.01.03032001332
    [Google Scholar]
  17. GanzR.A. EdmundowiczS.A. TaiganidesP.A. LiphamJ.C. SmithC.D. DeVaultK.R. HorganS. JacobsenG. LuketichJ.D. SmithC.C. Schlack-HaererS.C. KothariS.N. DunstC.M. WatsonT.J. PetersJ. OelschlagerB.K. PerryK.A. MelvinS. BemelmanW.A. SmoutA.J.P.M. DunnD. Long-term outcomes of patients receiving a magnetic sphincter augmentation device for gastroesophageal reflux.Clin. Gastroenterol. Hepatol.201614567167710.1016/j.cgh.2015.05.02826044316
    [Google Scholar]
  18. KushnerB.S. AwadM.M. MikamiD.J. ChandB.B. WaiC.J. MurayamaK.M. Endoscopic treatments for GERD.Ann. N. Y. Acad. Sci.20201482112112910.1111/nyas.1451133063344
    [Google Scholar]
  19. Rodríguez de SantiagoE. AlbénizE. Estremera-ArevaloF. Teruel Sanchez-VegazoC. Lorenzo-ZúñigaV. Endoscopic anti-reflux therapy for gastroesophageal reflux disease.World J. Gastroenterol.202127396601661410.3748/wjg.v27.i39.660134754155
    [Google Scholar]
  20. BortolottiM. Magnetic challenge against gastroesophageal reflux.World J. Gastroenterol.202127488227824110.3748/wjg.v27.i48.822735068867
    [Google Scholar]
  21. CalabreseF. PolettiV. AuriemmaF. PaduanoD. GentileC. FacciorussoA. FranchellucciG. De MarcoA. BrandaleoneL. OfosuA. SamantaJ. RamaiD. De LucaL. Al-LehibiA. ZulianiW. HassanC. RepiciA. MangiavillanoB. New perspectives in endoscopic treatment of gastroesophageal reflux disease.Diagnostics20231312205710.3390/diagnostics1312205737370952
    [Google Scholar]
  22. LemperleG. LemperleS.M. Gastroesophageal reflux disease (GERD): An overview of current minimal-invasive treatment potentials.Am. J. Biomed. Sci. Res.20192625326410.34297/AJBSR.2019.02.000619
    [Google Scholar]
  23. SavarinoV. MarabottoE. ZentilinP. FurnariM. BodiniG. De MariaC. ToloneS. De BortoliN. FrazzoniM. SavarinoE. Pathophysiology, diagnosis, and pharmacological treatment of gastro-esophageal reflux disease.Expert Rev. Clin. Pharmacol.202013443744910.1080/17512433.2020.175266432253948
    [Google Scholar]
  24. HagymásiK. MüllnerK. HerszényiL. TulassayZ. Update on the pharmacogenomics of proton pump inhibitors.Pharmacogenomics201112687388810.2217/pgs.11.421692617
    [Google Scholar]
  25. KhanW.Y. Pharmacogenomics in gastroenterology. Pharmacogenomics.Elsevier202327129710.1016/B978‑0‑443‑15336‑5.00011‑7
    [Google Scholar]
  26. HunginA.P.S. ScarpignatoC. KeeferL. CorsettiM. AnastasiouF. MurisJ.W.M. MendiveJ.M. KahrilasP.J. Review article: Rethinking the “ladder” approach to reflux‐like symptom management in the era of PPI “resistance” ‐ a multidisciplinary perspective.Aliment. Pharmacol. Ther.202255121492150010.1111/apt.1693035460095
    [Google Scholar]
/content/journals/ijghd/10.2174/0126662906299185240520112218
Loading

  • Article Type:
    Editorial
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test